Glutamate and its receptors in cancer
Open Access
- 9 March 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 121 (8), 933-944
- https://doi.org/10.1007/s00702-014-1182-6
Abstract
Glutamate, a nonessential amino acid, is a major bioenergetic substrate for proliferating normal and neoplastic cells on one hand and an excitatory neurotransmitter that is actively involved in biosynthetic, bioenergetic, metabolic, and oncogenic signaling pathways on the other. It exerts its action through a family of receptors consisting of metabotropic glutamate receptors (mGluRs) and ionotropic glutamate receptors (iGluRs), both of which have been implicated previously in a broad spectrum of acute and chronic neurodegenerative diseases. In this review, we discuss existing data on the role of glutamate as a growth factor for neoplastic cells, the expression of glutamate receptors in various types of benign and malignant neoplasms, and the potential roles that GluRs play in cancer development and progression along with their clinical significance. We conclude that glutamate-related receptors and their signaling pathways may provide novel therapeutic opportunities for a variety of malignant human diseases.Keywords
This publication has 99 references indexed in Scilit:
- Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survivalBritish Journal of Cancer, 2012
- Metabotropic glutamate receptors and cancerous growthWiley Interdisciplinary Reviews: Membrane Transport and Signaling, 2011
- Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanomaNature Genetics, 2011
- Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2011
- Exome sequencing identifies GRIN2A as frequently mutated in melanomaNature Genetics, 2011
- Kainate receptors coming of age: milestones of two decades of researchTrends in Neurosciences, 2011
- Glutamate and the biology of gliomasGlia, 2010
- A multigene predictor of outcome in glioblastomaNeuro-Oncology, 2009
- Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformationPigment Cell & Melanoma Research, 2008
- A role for glutamate in growth and invasion of primary brain tumorsJournal of Neurochemistry, 2008